Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-22 4:45 pm Purchase | 2025-05-20 | 13D | Indivior PLC INDV | Two Seas Capital LP | 11,880,926 9.500% | 301,107 (+2.60%) | Filing History |
| 2025-05-15 09:01 am Purchase | 2025-03-31 | 13G | Odyssey Marine Exploration, Inc. OMEX | Two Seas Capital LP | 2,953,690 9.990% | 5,943 (+0.20%) | Filing History |
| 2025-05-15 09:00 am Purchase | 2025-03-31 | 13G | Adaptimmune Therapeutics plc ADAP | Two Seas Capital LP | 123,178,110 8.000% | 34,167,234 (+38.39%) | Filing History |
| 2025-05-15 09:00 am Purchase | 2025-03-31 | 13G | Avadel Pharmaceuticals plc AVDL | Two Seas Capital LP | 4,946,449 5.100% | 4,946,449 (New Position) | Filing History |
| 2025-03-04 5:22 pm Sale | 2025-03-03 | 13D | Indivior PLC INDV | Two Seas Capital LP | 11,579,819 9.300% | -427,695 (-3.56%) | Filing History |
| 2025-02-14 09:32 am Purchase | 2024-12-31 | 13G | Odyssey Marine Exploration, Inc. OMEX | Two Seas Capital LP | 2,947,747 9.990% | 1,131,363 (+62.29%) | Filing History |
| 2025-02-14 09:31 am Purchase | 2024-12-31 | 13G | Adaptimmune Therapeutics plc ADAP | Two Seas Capital LP | 89,010,876 5.800% | 89,010,876 (New Position) | Filing History |
| 2025-01-17 4:20 pm Sale | 2025-01-15 | 13D | Indivior PLC INDV | Two Seas Capital LP | 12,007,514 9.600% | -1,022,513 (-7.85%) | Filing History |
| 2024-11-14 08:43 am Sale | 2024-09-30 | 13G | Odyssey Marine Exploration, Inc. OMEX | Two Seas Capital LP | 1,816,384 8.100% | -266,254 (-12.78%) | Filing History |
| 2024-11-14 08:42 am Sale | 2024-09-30 | 13G | Esperion Therapeutics, Inc. ESPR | Two Seas Capital LP | 6,584,278 3.300% | -1,101,842 (-14.34%) | Filing History |
| 2024-11-14 08:41 am Sale | 2024-09-30 | 13G | Arbutus Biopharma Corporation ABUS | Two Seas Capital LP | 8,387,388 4.400% | -654,539 (-7.24%) | Filing History |
| 2024-10-17 2:53 pm Sale | 2024-10-15 | 13D | Indivior PLC INDV | Two Seas Capital LP | 13,030,027 10.100% | -229,998 (-1.73%) | Filing History |
| 2024-06-21 6:04 pm Sale | 2024-06-20 | 13D | Indivior PLC INDV | Two Seas Capital LP | 13,260,025 9.900% | -295,114 (-2.18%) | Filing History |
| 2024-03-29 3:59 pm Sale | 2024-03-28 | 13D | Indivior PLC INDV | Two Seas Capital LP | 13,555,139 9.970% | -115,173 (-0.84%) | Filing History |
| 2024-02-14 10:50 am Sale | 2023-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | Two Seas Capital LP | 7,686,120 6.800% | -236,050 (-2.98%) | Filing History |
| 2024-02-14 10:48 am Sale | 2023-12-31 | 13G | Arbutus Biopharma Corporation ABUS | Two Seas Capital LP | 9,041,927 5.400% | -461,176 (-4.85%) | Filing History |
| 2024-02-14 10:38 am Purchase | 2023-12-31 | 13G | Odyssey Marine Exploration, Inc. OMEX | Two Seas Capital LP | 2,082,638 9.990% | 69,811 (+3.47%) | Filing History |
| 2023-11-21 08:00 am Purchase | 2023-11-21 | 13G | Arbutus Biopharma Corporation ABUS | Two Seas Capital LP | 9,503,103 5.700% | 9,503,103 (New Position) | Filing History |
| 2023-10-05 09:00 am Purchase | 2023-10-05 | 13G | Esperion Therapeutics, Inc. ESPR | Two Seas Capital LP | 7,922,170 7.400% | 7,922,170 (New Position) | Filing History |
| 2023-10-02 4:34 pm Purchase | 2023-09-22 | 13D | Indivior PLC INDV | Two Seas Capital LP | 13,670,312 9.900% | 13,670,312 (New Position) | Filing History |